BioAlliance seeks French Drug Agency’s nod to begin phase I trial with Fentanyl Lauriad (PharmaBiz)

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, announced the submission of a Fentanyl Lauriad clinical trial application to the French Drug Agency (AFSSaPS) and its approval by the Ethics Committee (Comité de Protection des Personnes).

[News Source]